What is Uabaco?
Uabaco, established in 2012, provides comprehensive drug testing services to state agencies, private sector businesses, and individual citizens. The company addresses the substantial financial and human costs associated with employee drug abuse, promoting drug-free workplace programs. By offering routine testing, Uabaco helps mitigate risks, reduce insurance costs, and ensure compliance with workers' compensation laws that may deny coverage for injuries resulting from illicit drug or alcohol use.
How much funding has Uabaco raised?
Uabaco has raised a total of $122K across 1 funding round:
Debt
$122K
Debt (2021): $122K with participation from PPP
Key Investors in Uabaco
PPP
Public-Private Partnership
What's next for Uabaco?
The recent large-scale, late-stage funding signifies Uabaco's transition into a scaling phase, likely aimed at expanding its service offerings, enhancing its technological infrastructure, or broadening its market reach. This strategic investment suggests confidence from backers in the company's business model and its capacity to address the persistent challenges of workplace substance abuse. Future growth may involve strategic partnerships or acquisitions to further solidify its market leadership in the drug testing industry.
See full Uabaco company page
